On the other hand, ROR1 exhibits aberrant expression in a wide spectrum of human cancers, including both hematological malignancies and solid tumors, and it is frequently associated with aggressive disease states and poor clinical outcomes [9,17]. The gene discussed is ROR1; the disease is cancer.